The next generation of proteins

Replacing a 100 year old method

One Platform to conquer all.

Our universal platform technology enables generating synthetic proteins at the highest yields and purity. This platform allows creating novel biological drugs with entire novel mechanisms of action and manufacture them at scale.

Supported by